CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BunyaVax is developing a rapid vaccine platform to respond to emerging viral threats. This innovative RNA particle technology allows for quick vaccine production, aiming to enhance preparedness against infectious disease outbreaks in both veterinary and human health.
BunyaVax builds unprecedented technology for cost-effective and rapid development of vaccinesagainst newly emerging viruses.
The platform can be a valuable tool in quickly controlling the spread of new virus strainsamong populations.
The timing of RAPID closely corresponds with a current focus of the vaccine industry on novel vaccineplatform technologies that enable rapid response to emerging threats.The BunyaVax RNA particle technology combines the efficacy of live vaccines with the safety of i…
BUNYAVAX BV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
